NetraMark Unveils AI-Discovered Treatment-Responsive Subgroups in A4 Alzheimer’s Trial at AD/PD Conference

2026-03-19 - 11:10

Results illustrate how NetraMark’s advanced AI can potentially support precision enrichment strategies in future trials Read More